BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Uranium Energy
UEC
$5.57B
| $11.4M | ﹤0.01% |
12,410,278
+306,543
| +3% | +$297K |
|
3177
Clearfield
CLFD
$374M
| $11.4M | ﹤0.01% |
815,704
+2,145
| +0.3% | +$27.7K |
|
3178
BCB Bancorp
BCBP
$161M
| $11.4M | ﹤0.01% |
824,167
+3,299
| +0.4% | +$43.8K |
|
3179
IES Holdings
IESC
$15.2B
| $11.4M | ﹤0.01% |
442,953
+22,307
| +5% | +$483K |
|
3180
Preformed Line Products
PLPC
$2.28B
| $11.3M | ﹤0.01% |
188,028
+195
| +0.1% | +$12.1K |
|
3181
Pure Cycle
PCYO
$261M
| $11.3M | ﹤0.01% |
900,208
+23,395
| +3% | +$274K |
|
3182
Personalis
PSNL
$1.51B
| $11.3M | ﹤0.01% |
1,035,130
+423,002
| +69% | +$4.4M |
|
3183
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.4B
| $11.3M | ﹤0.01% |
268,918
+102,176
| +61% | +$4.1M |
|
|
PRVL
3184
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $11.3M | ﹤0.01% |
711,774
+267,040
| +60% | +$3.41M |
|
|
EQC.PRD
3185
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $11.3M | ﹤0.01% |
398,621
+39,229
| +11% | +$1.12M |
|
3186
FVCBankcorp
FVCB
$333M
| $11.2M | ﹤0.01% |
804,514
+5,928
| +0.7% | +$82K |
|
|
TNAV
3187
DELISTED
Telenav Inc.
TNAV
| $11.2M | ﹤0.01% |
2,309,973
-473,742
| -17% | -$2.31M |
|
3188
Ocular Therapeutix
OCUL
$2.02B
| $11.2M | ﹤0.01% |
2,829,644
-243,630
| -8% | -$847K |
|
3189
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.8B
| $11.1M | ﹤0.01% |
122,061
+14,909
| +14% | +$1.36M |
|
3190
BlackBerry
BB
$5.26B
| $11.1M | ﹤0.01% |
1,730,197
+129,262
| +8% | +$710K |
|
|
DSKE
3191
DELISTED
Daseke, Inc. Common Stock
DSKE
| $11.1M | ﹤0.01% |
3,512,057
-123,982
| -3% | -$363K |
|
3192
American Superconductor
AMSC
$1.59B
| $11.1M | ﹤0.01% |
1,412,061
+40,082
| +3% | +$323K |
|
3193
Richmond Mutual Bancorp
RMBI
$254M
| $11.1M | ﹤0.01% |
694,483
+6,920
| +1% | +$99.5K |
|
3194
Protagonist Therapeutics
PTGX
$9.44B
| $11M | ﹤0.01% |
1,561,957
+478,755
| +44% | +$4.75M |
|
3195
Culp Inc
CULP
$44.1M
| $11M | ﹤0.01% |
805,102
+35,897
| +5% | +$551K |
|
|
CBAY
3196
DELISTED
Cymabay Therapeutics
CBAY
| $11M | ﹤0.01% |
5,589,851
-38,388
| -0.7% | -$144K |
|
3197
Prospect Capital
PSEC
$1.17B
| $11M | ﹤0.01% |
1,701,014
+61,399
| +4% | +$400K |
|
|
ENFC
3198
DELISTED
Entegra Financial Corp.
ENFC
| $10.9M | ﹤0.01% |
362,761
+14,014
| +4% | +$421K |
|
|
CSLT
3199
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $10.9M | ﹤0.01% |
8,207,719
+139,734
| +2% | +$195K |
|
|
SCWX
3200
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $10.9M | ﹤0.01% |
654,422
+4,692
| +0.7% | +$60.6K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.